Pharmaceutical products

Tender description

Project title: invitation to offer for NHS National Pharmaceuticals – Fulvestrant, Darunavir and Imatinib Offer reference number: CM/PHG/20/5627 Period of framework agreement: start date to be confirmed with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months potential periods of call-offs under the framework agreement: Fulvestrant: All regions: to commence as soon as possible with an end date of 1 May 2021 Darunavir: CESW Region: to commence as soon as possible with an end date of 1 May 2021 Imatinib: All regions: to commence as soon as possible with an end date of 31 October 2021. Project title: invitation to offer for NHS National Pharmaceuticals – Fulvestrant, Darunavir and Imatinib Offer reference number: CM/PHG/20/5627 Period of framework agreement: start date to be confirmed with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months Potential periods of call-offs under the framework agreement: Fulvestrant: All regions: to commence as soon as possible with an end date of 1 May 2021 Darunavir: CESW Region: to commence as soon as possible with an end date of 1 May 2021 Imatinib: All regions: to commence as soon as possible with an end date of 31 October 2021.